SCHEMBL7433532

SCHEMBL7433532

CC(C)(C)OC(=O)N1CC2CC(=NOCc3ccccc3)CC2C1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.48
JAK1 P23458 1/20 0.48
HSD11B1 P28845 1/20 0.47
GPR119 Q8TDV5 2/20 0.44
NR1H2 P55055 1/20 0.44
STS P08842 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
NAMPT P43490 1/20 0.43
RORC P51449 3/20 0.42
KCNK3 O14649 2/20 0.42
KCNK9 Q9NPC2 2/20 0.42
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.41
USP30 Q70CQ3 2/20 0.40
TACR1 P25103 1/20 0.40
YAP1 P46937 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18484113 0.85 HSD11B1 (0.45) JAK2JAK1HSD11B1GPR119STS
SCHEMBL31288410 0.81 JAK2 (0.53) JAK2JAK1GPR119NR1H2STS
SCHEMBL30993456 0.81 JAK2 (0.53) JAK2JAK1GPR119NR1H2STS
SCHEMBL6095209 0.81 JAK2 (0.53) JAK2JAK1GPR119NR1H2STS
SCHEMBL27534101 0.81 ESR2 (0.47) JAK2JAK1HSD11B1GPR119NR1H2
SCHEMBL7333103 0.81 NPC1 (0.42) HSD11B1NPC1RAB9A
SCHEMBL2817602 0.79 ESR2 (0.43) JAK2JAK1HSD11B1GPR119NR1H2
SCHEMBL994232 0.79 ESR2 (0.43) JAK2JAK1HSD11B1GPR119NR1H2
SCHEMBL18986945 0.78 JAK2 (0.53) JAK2JAK1HSD11B1GPR119NR1H2
SCHEMBL16836282 0.77 JAK2 (0.45) JAK2JAK1GPR119STSKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5627190-A TREATMENT OF ANXIETY, PSYCHOSES, DEPRESSION, ORGASTROINTESTINAL DISORDERS, 5-HYDROXYTRYPTAMINE ANTAGONISTS G. D. SEARLE & CO. (US) 1997-05-06 US disclosed
US-5612366-A USEFUL IN TREATMENT OF CENTRAL NERVOUS SYSTEM AND GASTROINTESTINAL MOTILITY DISORDERS G. D. SEARLE & CO. (US) 1997-03-18 US disclosed
US-5534521-A SEROTONIN ANTAGONISTS G. D. SEARLE & CO. (US) 1996-07-09 US disclosed
US-5521193-A SEROTONIN AGONISTS AND ANTAGONISTS G. D. SEARLE & CO. (US) 1996-05-28 US disclosed
US-5516782-A FOR TREATMENT OF ANXIETY, PSYCHOSES, DEPRESSION OR GASTROINTESTINAL MOTILITY DISTURBANCES G. D. SEARLE & CO. (US) 1996-05-14 US disclosed
US-5430040-A Anxiolytic agents, antidepressants, antiserotonine agents; treatment of psychosis, gastrointestinal disorders G. D. SEARLE & CO. (US) 1995-07-04 US disclosed
US-5318977-A New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents G. D. SEARLE & CO. (US) 1994-06-07 US disclosed
US-5280029-A Containing imidazolo(1,5-a)pyridine G. D. SEARLE & CO. (US) 1994-01-18 US disclosed
US-5227377-A Serotonin 5-HT3 receptor antagonists G. D. SEARLE & CO. (US) 1993-07-13 US disclosed
US-5219850-A Anyiolytic agents, gastrointestinal disorders, antiserotonin agents G. D. SEARLE & CO. (US) 1993-06-15 US disclosed
EP-0528026-A1 NEW MESO-AZACYCLIC AROMATIC ACID AMIDES AND ESTERS AS NOVEL SEROTONERGIC AGENTS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
EP-0504680-A1 New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents G.D. Searle & Co. (US) 1992-09-23 EP disclosed